Company news
TuHURA Biosciences, Inc. news in 2022
TuHURA Biosciences, Inc.'s news releases, calls and decks from 2022, newest first.
Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
December 14, 2022
Kintara Therapeutics to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
November 30, 2022
Kintara Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 29, 2022
Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer
November 27, 2022
Kintara Therapeutics Presents Three Posters at the 2022 Society for Neuro-Oncology Annual Meeting
November 17, 2022
Kintara Announces One-for-Fifty Reverse Stock Split
November 10, 2022
Kintara Therapeutics Announces Fiscal 2023 First Quarter Financial Results and Provides Corporate Update
November 8, 2022
Kintara Therapeutics Pauses REM-001 Program to Conserve Funds to Support VAL-083 International Registrational Study
October 18, 2022
Kintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Update
September 26, 2022
Kintara Therapeutics Announces Three Abstracts Have Been Accepted for the 2022 Society for Neuro-Oncology Annual Meeting
September 7, 2022
Kintara Therapeutics Receives Study May Proceed Letter from the FDA for REM-001 for Cutaneous Metastatic Breast Cancer
August 8, 2022
Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital
August 2, 2022
Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference
June 20, 2022
Kintara Therapeutics to Present at the JMP Securities Life Sciences Conference
June 9, 2022
Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
June 2, 2022
Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma
May 26, 2022
Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update
May 12, 2022